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Abstract Perceived risk is a complex concept that influences
the genetic counseling process and can affect client coping
and behavior. Although the association between family
history and risk perception is well recognized in the literature,
no studies have explored this relationship specifically in those
seeking genetic susceptibility testing for a common chronic
condition. REVEAL is a randomized trial assessing the
impact of APOE disclosure and genetic risk assessment for
Alzheimer’s disease (AD). Using baseline REVEAL data, we
hypothesized that there would be a significant association
between the degree of AD family history and risk perception
of AD, and that this relationship would be stronger in those
who believed that genetics is a very important AD risk factor.
In our sample of 293 participants, we found that a higher self-
perceived risk of AD was associated with strength of family
history of AD (p<0.001), belief in genetics as an important
AD risk factor (p<0.001), being female (p<0.001) and being
Caucasian (p=0.02). These results are the first to demon-
strate the association between family history and risk
perception in persons volunteering for genetic susceptibility
testing for a common complex disease.
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Introduction
Family history is one of the most significant, consistent,
and efficient ways to evaluate genetic disease risk (Bennett
2004; DiLorenzo et al. 2006). It can inform both personal
and reproductive risks (Bennett 1999) and can be used to
assess risk for diseases with Mendelian inheritance, as well
as multifactorial conditions that depend on both genetic and
environmental contributions (Wattendorf & Hadley 2005;
Yoon et al. 2003). Family history is a known risk factor for
many common chronic diseases including heart disease,
cancer, diabetes and Alzheimer’s disease (DiLorenzo et al.
2006; Green et al. 2002; Scheuner et al. 1997; Yoon et al.
2003), and is being promoted for wide-spread use in risk
assessment and preventive medicine (Centers for Disease
Control and Prevention, National Office of Public Health
Genomics).
There is a high general awareness of the increased risk
conferred by a family history of disease; those with cancer,
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heart disease and diabetes in their family tend to have
significantly higher risk perceptions for these diseases than
those without such a family history (Absetz 2000; DiLorenzo
et al. 2006; Donovan & Tucker 2000; Facione 2002;
Katapodi et al. 2004; Montgomery et al. 2003). However
risk perception, as defined as the risk perceived before any
education, counseling, or testing, is a complex concept
encompassing acknowledgement of family history as well
as personal experience and perceived disease burden
(d’Agincourt-Canning 2005; Frich et al. 2006; Henderson
& Maguire 2000; McAllister 2003; Walter & Emery 2005).
Beliefs about inheritance and disease causation also inform
risk perception, and lay understandings of genetics and
heredity often differ from those held by clinicians (Henderson
& Maguire 2000; McAllister 2003; Richards & Ponder
1996). In addition, demographic factors of age, sex, race,
education and income have been reported to have varying
effects on perceived risk of complex disease (DiLorenzo
et al. 2006; Katapodi et al. 2004; Lipkus & Hollands 1999;
Lipkus et al. 1999).
Perceived risk is an important predictor of the reactions
to and outcomes of genetic counseling. It affects disease-
specific worry (Price et al. 2007), coping (Gooding et al.
2006; McAllister 2003) and engagement in health behav-
iors such as cancer screening and uptake of preventative
therapies (Katapodi et al. 2004; Marteau & Weinman 2006;
Matloff et al. 2006). Perceived risk can be more influential
than objective risk estimates (Meiser et al. 2001), and
inaccuracies have been shown to persist even after genetic
counseling (Cull et al. 1999). Most previous studies
exploring family history and risk perception have been
conducted from samples of the general population, or have
been targeted to women seeking BRCA1/2 testing for
breast cancer risk assessment. No studies to date have
explored the association between family history and risk
perception specifically in those seeking genetic susceptibility
testing for a common chronic condition. The discovery of
genetic markers associated with complex disease continues to
increase (Couzin & Kaiser 2007) contributing to the growing
availability of genetic susceptibility testing both clinically
and through direct-to-consumer private companies (Pollack
2006). This paradigm shift in clinical genetics from
diagnosis and treatment to risk assessment and prevention
(Collins 1997) provides a compelling reason to re-examine
this relationship in those seeking genetic susceptibility
testing for complex disease.
The purpose of this study was to explore the association
between family history and risk perception in those seeking
genetic susceptibility testing for Alzheimer’s disease (AD)
risk, and to assess how a belief in genetics may influence
this relationship. We hypothesized that (1) strength of
family history of AD would be significantly associated with
risk perception and (2) this association would be stronger
for those who endorsed genetics as an important AD risk
factor.
Background
The REVEAL (Risk Evaluation and Education for Alzheimer’s
Disease) Study is a multi-site clinical trial that provides genetic
susceptibility testing for Alzheimer’s disease. Family history is
a well-established risk factor for AD (Lautenschlager et al.
1996; Silverman et al. 1994), with risks ranging from 18–
41%, depending on gender and race, for first-degree relatives
of AD patients, compared to the general population risk of
10–15% (Green et al. 2002; Lautenschlager et al. 1996). The
apolipoprotein E gene (APOE) is a susceptibility marker for
Alzheimer’s, with the ε4 allele conferring a 3-15X greater
risk, depending on whether it is in the homozygous or
heterozygous state (Farrer et al. 1997). There are several
consensus statements recommending against the use of APOE
testing for AD risk assessment due to the potential for
misunderstanding of the probabilistic information, and the
absence of treatment and prevention options for the disease
(Brodaty et al. 1995; American College of Medical Genetics
1995; Relkin & Gandy 1996). However, there is evidence that
relatives of persons with AD are concerned about their own
risk and want to better understand this risk (Green 2002).
Those volunteering for such testing are motivated by the
potential to make personal, family, and financial plans in
response to the results, as well as a desire to contribute to
research (Roberts et al. 2003b). In the first funding cycle of
REVEAL, trial results suggested that AD genetic susceptibil-
ity testing could be provided safely using an extended
education and counseling protocol by a trained genetic
counselor (Roberts et al. 2005). The current study sought to
examine the impact of providing this information in a
condensed, more clinically feasible protocol.
Methods
Study Design
First-degree relatives of individuals with AD were ascer-
tained largely through self-referral, learning of the study
through website and pamphlet advertisements, as well as
through physician referral and community outreach efforts.
Exclusion criteria included persons with current, untreated
anxiety or depression, those experiencing cognitive diffi-
culties, those with a family history of AD-onset of less than
60 years of age, and those with more than one affected first-
degree relative. Participants completed a phone interview
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and mailed pre-educational survey which elicited demo-
graphic information as well as attitudes towards and
knowledge about AD, genetics, and genetic testing.
Participants were then randomized into the Condensed
study arm, which received a mailed educational brochure,
or Extended study arm, which had an in-person
educational session. All participants had genetic testing
and disclosure of their APOE genotype with AD genetic
risk assessment by either a physician or genetic
counselor. Participants received lifetime risks for devel-
oping AD depending on APOE genotype, gender, race,
and age, with risk estimates ranging from 13–77%.
Follow-up measures included a one week follow-up
phone call, two in-person visits at 6 weeks and 6 months
post-disclosure, and a 12 month post-disclosure mailed
survey. Results of the primary analysis will be published
separately. For the purposes of this analysis, only baseline
measures elicited prior to the education session were
examined. The study was conducted at four sites: Boston
University, Weill Medical College of Cornell University,
Case Western Reserve University, and Howard University,




The main outcome measure for this study was baseline
perceived risk of developing AD, which was ascertained in
the pre-educational survey using a rating scale of 0–100%.
This method has been used to measure disease risk
perception in previous studies and has demonstrated good
reliability (0.85) and validity (Durfy et al. 1999; Erblich
et al. 2000; Montgomery et al. 2003).
Independent Variables
Demographics Age, sex, race (African American versus
Caucasian), education and income, as well as current status
as a caregiver for someone with AD were included in our
analyses.
Family History The number of family members with AD,
living and deceased, for each participant, was elicited
during the intake with the questions “Do you have any
living or deceased family members—related to you by
blood—who have been affected by Alzheimer’s disease?”
and “If yes, please tell me how you are/were related to each
of your family members.” Although medical records were
not required to confirm this report, a set of standardized
questions were asked in order to obtain more details about
age and nature of onset of symptoms for verification
purposes. For analyses, family history was classified as
having one relative versus having more than one relative
with AD.
Perceptions of AD Causation Belief in genetics as an
important AD risk factor was quantified using the question
“How important do you believe the following factors are in
increasing one’s risk of Alzheimer’s disease?” Genetics/
heredity was listed as one of the factors, with a five point
Likert scale ranging from “not important” to “very
important.”
Data Analyses
All analyses were conducted using SAS 9.1 software. For
analysis, the family history variable was dichotomized into
one affected relative versus more than one affected relative.
In the pre-educational survey, participants rated the impor-
tance of genetics/heredity to increasing one’s risk for AD
on a 5 point Likert scale. For purposes of analysis,
responses 1, 2, and 3 were collapsed and responses 4 and
5 were collapsed, creating a dichotomous variable. Student’s
t-tests were used to analyze differences between those with
one relative with AD versus those with more than one affected
relative. Bivariate linear regression analyses were used to
assess predictors of baseline risk perception. These variables
included family history of AD, age (continuous variable), sex,
race (White versus African American), income (≤50 K versus
>50 K), education level (< high school versus ≥high school),
and current status as a caregiver for a relative with AD. In
addition, two multivariate models were run. The first included
all predictor variables except for belief in genetics as an
important AD risk factor. A second full model was run
including this variable. An interaction analysis of family
history and belief in genetics was also conducted.
Results
Participant Characteristics
Of our 293 participants, 53% entered the study through
self-referral, with 38% recruited through physician referral
or other research studies, and 9% from community outreach
efforts. Over half of the sample (56%) reported having only
one relative with AD, and 24%, 12%, 4%, 1%, and 3%
reported two, three, four, five, and six affected relatives
respectively. Majority of the sample was Caucasian, female,
with a high level of income and education (Table 1).
Ninety-two percent of participants reported their affected
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first-degree relative to be a parent and 8% reported an affected
sibling (data not shown). Those with more than one relative
with AD had a higher baseline risk perception (p<0.001),
were younger (p=0.001), and had a stronger belief in
genetics as an important AD risk factor (p=0.017) than
those with only one affected relative. These groups did not
differ significantly in sex, race, income, education level, or
current status as a caregiver for someone with AD (Table 2).
Risk Perception Analyses
Family history (i.e. having one affected relative versus
having more than one affected relative) was significantly
associated with risk perception in our multivariate regres-
sion analysis (38.5% vs 46.5%, β=8.0, p<0.001) after
adjusting for age, sex, race, income, education level,
caregiver status, and belief in genetics as an important
AD risk factor (Table 3). Thus those with more than one
relative with AD had on average an 8% higher baseline risk
perception than those with only one relative with AD. In
this model, sex, race, and belief in genetics remained
significant predictors of baseline risk perception as well. An
evaluation of whether the association between family
history and risk perception varied by one’s belief in
genetics was not significant, suggesting that the effect of
family history on baseline risk perception was not depen-
dent on the strength of an individual’s belief in genetics as
an AD risk factor.
Discussion
The purpose of this study was to test the hypothesis that
strength of AD family history is significantly associated with
risk perception in those seeking genetic susceptibility testing
for AD. Our results support this finding. We also believed
that for those who placed more importance on genetics,
family history would be more meaningful and would have a
stronger impact on risk perception. However this hypothesis
was not supported in our results. We found that having more
affected relatives predicts a higher risk perception, regardless
of how strongly one believes in genetics.
Similar findings were reported by Drossaert et al. (1996)
who demonstrated that breast cancer risk perception was
increased by being aware of family history as a risk factor,
but was also influenced by personal experience with breast
cancer. Perceptions of disease risk are informed by the
number of affected relatives and age of onset in their
family, in addition to personal factors such as the nature of
the relationship with the affected family member, perceived
resemblance to that individual, and personal experience
with the disease (Walter et al. 2004). Lock et al. (2007)
extend this interpretation of familial risk in the description
of “blended inheritance.” Interviews with relatives of AD
patients revealed that many believe that the disease “runs in
the family,” but conflate genotype and phenotype in
explaining disease inheritance. Participants often cited the
number of traits shared with the affected individual in
explaining their own personal risk. With complex con-
ditions such as AD, where inheritance patterns are less
precise, there is more latitude for personal interpretation of
family history and disease risk.
Different causal attributions can also affect risk percep-
tion. We found that those who believed more strongly in
genetics as an AD risk factor had a higher perceived risk of
Table 1 Participant Characteristics
Characteristic (N=293) n (%)
Family history of AD: n (%) 1 affected relative 163 (56%)
Age (mean ± SD) 57.9±10.6
Sex: n (%) Female 208 (71%)
Race: n (%) Caucasian 232 (79%)
Income: n (%) >50 k 204 (70%)
Education: n (%) > college 124 (42%)
Serve as a caregiver for a relative w/ AD: n (%) yes 38 (13%)
Belief in genetics as an AD risk factor: 229 (78%)
n (%) important/very important
Table 2 Participant Characteristics: 1 vs. >1 Relative with AD
Variable 1 relative with AD >1 relative with AD p-value
(n=163) (n=130)
Risk perception, % mean ± SD 46.4±23.2 57.8±19.1 <0.001
Age, mean ± SD 59.7±10.8 55.7±10.0 0.001
Sex, n (%) Female 115 (71) 93 (72) 0.853
Race, n (%) White 123 (76) 109 (84) 0.079
Income, n (%) >50 K per year 107 (66) 97 (75) 0.097
Education, n (%) > college 68 (42) 56 (43) 0.269
Belief in genetics as an AD risk factor, n (%) very important 119 (73) 110 (85) 0.017
Serve as a caregiver for a relative with AD, n (%) yes 25 (15) 13 (10) 0.177
*Significant differences (p<0.05) indicated in italic
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AD. Genetic disease is often believed to be more severe
and uncontrollable, and genetic information may be valued
more than other types of health information (Green &
Botkin 2003; Shiloh 2006). This could explain the stronger
feelings of vulnerability in this group. Given that REVEAL
is presented as a genetic risk study, it was surprising that
there was some variability, albeit relatively little, in how
strongly participants rated genetics as an important AD risk
factor. It seems that even in those seeking genetic testing to
inform their risk of Alzheimer’s disease, there is not
uniform agreement on how important this test may be in
determining their risk. Although not specifically addressed
in our study, it is likely that a belief in shared environmen-
tal risk factors may also impact interpretations of familial
risk, and should be explored in future studies.
Caucasian participants were more likely to have a higher
risk perception than African Americans. Other studies
support this finding of racial distinctions between Cauca-
sians and African Americans in their attitudes towards AD
and genetic testing, with African Americans generally
anticipating less negative consequences from a positive test
result, indicating less perceived threat of AD, and showing
less awareness about AD (Hipps et al. 2003; Roberts et al.
2003a; Sadler et al. 2005). This is in contrast to current
research suggesting that African American relatives of AD
patients actually have a higher risk of developing dementia
than Caucasians (Green et al. 2002). This contrast high-
lights the need for better education of the public regarding
various risk factors for AD. Women also had significantly
higher risk perceptions than men, which is in line with
current scientific evidence (Farrer et al. 1997), but may be
reflective of a general gender difference in perception of
disease risk (Gustafson 1998).
Our results were limited by the fact that we only enrolled
those with a family history of AD, and therefore could not
assess self-perceived risk in those with no family history. In
addition, our single measure of belief in genetics as an AD
risk factor could not be assessed for validity. Although the
generalizability of our study was strengthened by the
inclusion of over 20% African Americans in our sample,
future research should be directed towards samples with
more diverse racial backgrounds.
Conclusions
This is the first study to present quantitative data on the
relationship between family history and risk perception in
those seeking genetic susceptibility testing for a common
disease polymorphism. Unlike previous studies examining
risk perception for complex disease, our results are
reflective of those actually enrolled in a genetic testing
protocol, rather than in response to a survey or hypothetical
scenario, and thus may be more applicable to the clinical
setting. We also focused on measures that were collected
prior to education and counseling, providing insights into
baseline perceptions of risk and family history.
With the number of genetic tests offered for disease risk
assessment rapidly increasing, there is a need to better
understand personal interpretations of familial risk in those
seeking this testing. Clinicians are now being faced with the
challenge of interpreting personal genetic profiles obtained
from the many emerging direct-to-consumer genetic testing
companies (Offit 2008). Among the various considerations
concerning the evaluation of this industry is the test’s
clinical utility, or how it can be translated into clinical
practice (Hunter et al. 2008). Gaining insight into perceived
risk for complex disease can impact clinical utility by
improving risk communication, optimizing coping strate-
gies, and encouraging the uptake of preventive health
behaviors. Future studies should be directed towards
replicating these findings in those seeking genetic risk
assessment for other complex diseases as this testing
becomes more widely available.
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